Key statistics
Valuation, profitability, and growth metrics
- Market cap
- 259.36M USD
- Enterprise value
- 107.67M USD
- Trailing P/E
- —
- Forward P/E
- -1.60
- Price / sales
- 4.44
- Price / book
- 1.43
- EV / EBITDA
- -0.96
- Beta
- 0.71
- Dividend yield
- —
- Profit margin
- -183.90%
- Return on equity
- -95.89%
- Debt / equity
- 4.63
- Earnings growth
- —
- Revenue growth
- +21.20%
- Free cash flow
- -69.95M USD
- Operating cash flow
- -108.42M USD
- Shares outstanding
- 294.76M
- Sector
- Healthcare
- Industry
- Biotechnology
Updated Sep 2, 2026, 4:11 AM